Matt Biegler

Stock Analyst at Oppenheimer

(0.03)
# 4,657
Out of 4,667 analysts
1
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:

Stocks Rated by Matt Biegler

OnKure Therapeutics
Oct 10, 2024
Initiates: Outperform
Price Target: $35
Current: $16.00
Upside: +118.75%